Cite
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
MLA
Migden, Michael R., et al. “Treatment with Two Different Doses of Sonidegib in Patients with Locally Advanced or Metastatic Basal Cell Carcinoma (BOLT): A Multicentre, Randomised, Double-Blind Phase 2 Trial.” Lancet Oncology, vol. 16, no. 6, June 2015, pp. 716–28. EBSCOhost, https://doi.org/10.1016/S1470-2045(15)70100-2.
APA
Migden, M. R., Guminski, A., Gutzmer, R., Dirix, L., Lewis, K. D., Combemale, P., Herd, R. M., Kudchadkar, R., Trefzer, U., Gogov, S., Pallaud, C., Yi, T., Mone, M., Kaatz, M., Loquai, C., Stratigos, A. J., Schulze, H.-J., Plummer, R., Chang, A. L. S., & Cornélis, F. (2015). Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncology, 16(6), 716–728. https://doi.org/10.1016/S1470-2045(15)70100-2
Chicago
Migden, Michael R, Alexander Guminski, Ralf Gutzmer, Luc Dirix, Karl D Lewis, Patrick Combemale, Robert M Herd, et al. 2015. “Treatment with Two Different Doses of Sonidegib in Patients with Locally Advanced or Metastatic Basal Cell Carcinoma (BOLT): A Multicentre, Randomised, Double-Blind Phase 2 Trial.” Lancet Oncology 16 (6): 716–28. doi:10.1016/S1470-2045(15)70100-2.